Safety and Immunogenicity of 3 Doses of BNT162b2 and CoronaVac in Children and Adults with Inborn Errors of Immunity
Daniel Leung,1,* Xiaofeng Mu,1,* Jaime S Rosa Duque,1,* Samuel MS Cheng,2,* Manni Wang,1 Wenyue Zhang,1 Yanmei Zhang,1 Issan YS Tam,1 Toby SS Lee,1 Jennifer HY Lam,1 Sau Man Chan,1 Cheuk Hei Cheang,1 Yuet Chung,1 Howard HW Wong,1 Amos MT Lee,1 Wing Yan Li,1 Sara Chaothai,2 Leo CH Tsang,2 Gilbert T Chua,1 Kai-Ning Cheong,3 Elaine YL Au,4 Janette SY Kwok,5 Koon Wing Chan,1 Patrick CY Chong,6 Pamela PW Lee,1 Marco HK Ho,6 Tsz Leung Lee,3 Wenwei Tu,1,† Malik Peiris,2,7,† Yu Lung Lau,1,†
1 Department of Paediatrics and Adolescent Medicine, The University of Hong Kong, Hong Kong, China
2 School of Public Health, The University of Hong Kong, Hong Kong, China
3 Hong Kong Children’s Hospital, Hong Kong, China
4 Division of Clinical Immunology, Department of Pathology, Queen Mary Hospital, Hong Kong, China
5 Division of Transplantation and Immunogenetics, Department of Pathology, Queen Mary Hospital, Hong Kong, China
6 Virtus Medical, Hong Kong, China
7 Centre for Immunology & Infection C2i, Hong Kong, China
*, denotes co-first authors who contributed equally
, denotes co-corresponding authors who contributed equally